Context Therapeutics Bolsters Board with Industry Veterans
Company Announcements

Context Therapeutics Bolsters Board with Industry Veterans

An announcement from Context Therapeutics (CNTX) is now available.

Context Therapeutics Inc. has expanded its Board of Directors from five to seven members by appointing Dr. Karen L. Smith and Dr. Luke Walker, both bringing over 20 years of experience in the biopharmaceutical industry. Dr. Smith, known for her role in developing several approved drugs across various therapeutic areas, and Dr. Walker, with a strong background in clinical development and executive leadership, will also join the Compensation and Nominating Committees, respectively. Both appointees have been granted stock options and will receive cash compensation as part of the company’s non-employee director compensation program.

See more data about CNTX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyContext Therapeutics files $250M mixed securities shelf
TheFlyContext Therapeutics management to meet with Maxim
TheFlyContext Therapeutics management to meet with Piper Sandler
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App